Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacob M Rowe

Showing results (101-110 of 275) with videos related to

Pageof 28
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 27, 2016
Allogeneic Stem Cell Transplantation in Congenital Hemoglobinopathies Using a Tailored Busulfan-Based Conditioning Regimen: Single-Center ExperienceIrina Zaidman, Jacob M Rowe, Abdalla Khalil, et al.
American Journal of Hematology|November 3, 2006
Differentiation syndrome with lethal lung injury after arsenic trioxide treatment for myelodysplastic syndromeYishay Ofran, Irit Avivi, Benjamin Gesundheit, et al.
Blood Reviews|February 28, 2012
Hyperleukocytosis, leukostasis and leukapheresis: practice managementChezi Ganzel, Joanne Becker, Paul D Mintz, et al.
Therapeutic Drug Monitoring|May 29, 2004
A simple approximation for busulfan dose adjustment in adult patients undergoing bone marrow transplantationErica Hoffer, Luiza Akria, Arek Tabak, et al.
Bone Marrow Transplantation|September 19, 2019
Newly diagnosed myeloma patients with low-burden disease may benefit from tandem autologous stem cell transplantation: results of long-term follow-upNoam Benyamini, Noa Lavi, Tsila Zuckerman, et al.
Thrombosis Research|May 24, 2005
Predictive factors of bleeding and thrombosis during induction therapy in acute promyelocytic leukemia-a single center experience in 34 patientsNajib Dally, Ron Hoffman, Nuhad Haddad, et al.
Current Drug Safety|September 7, 2012
Pharmacokinetic and pharmacogenetic analysis of oral busulfan in stem cell transplantation: prediction of poor drug metabolism to prevent drug toxicityNorberto Krivoy, Tsila Zuckerman, Hela Elkin, et al.
Annals of Hematology|May 24, 2011
Low incidence of long-term respiratory impairment in Hodgkin lymphoma survivorsIrit Avivi, Emilia Hardak, Beatrice Shaham, et al.
Pediatric Diabetes|August 6, 2008
Insulin-related metabolism following hematopoietic stem cell transplantation in childhoodRonit Elhasid, Yael A Leshem, Myriam Weyl Ben Arush, et al.
Fertility and Sterility|July 3, 2007
Gonadotropin-releasing hormone agonist decreases chemotherapy-induced gonadotoxicity and premature ovarian failure in young female patients with Hodgkin lymphomaZeev Blumenfeld, Irith Avivi, Ari Eckman, et al.
Pageof 28

Showing results (101-110 of 275) with videos related to

Sort By:
Pageof 28
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 27, 2016
Allogeneic Stem Cell Transplantation in Congenital Hemoglobinopathies Using a Tailored Busulfan-Based Conditioning Regimen: Single-Center ExperienceIrina Zaidman, Jacob M Rowe, Abdalla Khalil, et al.
American Journal of Hematology|November 3, 2006
Differentiation syndrome with lethal lung injury after arsenic trioxide treatment for myelodysplastic syndromeYishay Ofran, Irit Avivi, Benjamin Gesundheit, et al.
Blood Reviews|February 28, 2012
Hyperleukocytosis, leukostasis and leukapheresis: practice managementChezi Ganzel, Joanne Becker, Paul D Mintz, et al.
Therapeutic Drug Monitoring|May 29, 2004
A simple approximation for busulfan dose adjustment in adult patients undergoing bone marrow transplantationErica Hoffer, Luiza Akria, Arek Tabak, et al.
Bone Marrow Transplantation|September 19, 2019
Newly diagnosed myeloma patients with low-burden disease may benefit from tandem autologous stem cell transplantation: results of long-term follow-upNoam Benyamini, Noa Lavi, Tsila Zuckerman, et al.
Thrombosis Research|May 24, 2005
Predictive factors of bleeding and thrombosis during induction therapy in acute promyelocytic leukemia-a single center experience in 34 patientsNajib Dally, Ron Hoffman, Nuhad Haddad, et al.
Current Drug Safety|September 7, 2012
Pharmacokinetic and pharmacogenetic analysis of oral busulfan in stem cell transplantation: prediction of poor drug metabolism to prevent drug toxicityNorberto Krivoy, Tsila Zuckerman, Hela Elkin, et al.
Annals of Hematology|May 24, 2011
Low incidence of long-term respiratory impairment in Hodgkin lymphoma survivorsIrit Avivi, Emilia Hardak, Beatrice Shaham, et al.
Pediatric Diabetes|August 6, 2008
Insulin-related metabolism following hematopoietic stem cell transplantation in childhoodRonit Elhasid, Yael A Leshem, Myriam Weyl Ben Arush, et al.
Fertility and Sterility|July 3, 2007
Gonadotropin-releasing hormone agonist decreases chemotherapy-induced gonadotoxicity and premature ovarian failure in young female patients with Hodgkin lymphomaZeev Blumenfeld, Irith Avivi, Ari Eckman, et al.
Pageof 28